Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06279013 · ClinicalTrials.gov registry record · NA

Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment

A NA study of Malignant Solid Neoplasm and Hematopoietic and Lymphatic System Neoplasm, sponsored by NRG Oncology.

Recruiting
Registry status
NA
Development phase
600
Enrollment target
20
Study locations

NCT06279013 is a NA study of Malignant Solid Neoplasm and Hematopoietic and Lymphatic System Neoplasm that is actively recruiting participants, run by NRG Oncology. The registered enrollment target is 600 participants, below the 1,137-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (47% lower). The trial reports 20 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06279013, a NA study of Malignant Solid Neoplasm and Hematopoietic and Lymphatic System Neoplasm, is actively recruiting participants, sponsored by NRG Oncology.

RECRUITING
Registry status
NA
Development phase
600 participants
Enrollment target
20
Study locations

Study Summary

In this clinical trial, symptom monitoring (interactive voice response \[IVR\] is compared to automated telephone symptom management \[ATSM\] and telephone interpersonal counseling \[TIPC\]) for reducing symptom burden and psychological distress (depressive and anxiety symptoms) among people receiving oral anti-cancer treatment. Symptoms are the number one driver of treatment interruptions and unscheduled health services use. To reduce the risk of these events, symptom monitoring and management are necessary. However, these services are not implemented routinely, especially in the community oncology settings. Further, depressive and anxiety symptoms are a key barrier to enacting symptom self-management strategies. IVR is a form of symptom monitoring where patients, when called, enter their symptom ratings over the phone. Their symptom summary is sent to their provider, and patients may be advised to reach out to their oncology provider, based on their symptoms. The ATSM intervention combines IVR assessments with a Symptom Management and Survivorship educational handbook with self-management strategies. Patients receiving ATSM enter their symptom ratings over the phone and have their symptoms reported to their provider, but patients are also directed to the handbook for strategies to manage elevated symptoms. Patients receiving ATSM who report being anxious, discouraged, or sad will also receive TIPC, which targets psychological distress and its connection to social support and interpersonal communication. Information gathered from this study may help researchers learn more about the best ways to manage patient symptoms and improve patient outcomes.

Conditions Studied

Malignant Solid Neoplasm Hematopoietic and Lymphatic System Neoplasm

Interventions

  • OTHER Medical Chart Review
  • OTHER Interview
  • BEHAVIORAL Health Education
  • OTHER Counseling
  • OTHER Monitoring

Study Locations (20)

Illinois

  • John H Stroger Jr Hospital of Cook County - Chicago
  • Carle at The Riverfront - Danville
  • Carle Physician Group-Effingham - Effingham
  • Carle Physician Group-Mattoon/Charleston - Mattoon
  • Carle Cancer Center - Urbana

Hawaii

  • Queen's Cancer Cenrer - POB I - Honolulu
  • Queen's Medical Center - Honolulu
  • Queen's Cancer Center - Kuakini - Honolulu
  • The Queen's Medical Center - West Oahu - ‘Ewa Beach

Georgia

  • Phoebe Putney Memorial Hospital - Albany
  • Augusta Oncology Associates PC-D'Antignac - Augusta
  • Augusta University Medical Center - Augusta

South Carolina

  • AnMed Health Cancer Center - Anderson
  • Medical University of South Carolina - Charleston

Arizona

  • Cancer Center at Saint Joseph's - Phoenix

Arkansas

  • CARTI Cancer Center - Little Rock

Kansas

  • Central Care Cancer Center - Garden City - Garden City

Louisiana

  • University Medical Center New Orleans - New Orleans

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2024-10-14
Est. Completion 2028-05-01
Phase NA

Sponsor

NRG Oncology

64 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06279013

The ClinicalTrials.gov registry entry for NCT06279013 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,137-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (47% lower). The listed sponsor is NRG Oncology, which has 64 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 5 interventions - of which Medical Chart Review is the first listed.

NCT06279013 reports 20 study locations spanning 10 distinct geographic areas - top geographies include Illinois, Hawaii, Georgia.

Frequently Asked Questions

What is clinical trial NCT06279013 about?

NCT06279013 is a clinical study titled "Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment". In this clinical trial, symptom monitoring (interactive voice response \[IVR\] is compared to automated telephone symptom management \[ATSM\] and telephone interpersonal counseling \[TIPC\]) for reducing symptom burden and psychological distress (depressive and anxiety symptoms) among people receivi...

What is the current status of trial NCT06279013?

This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2024-10-14. Estimated completion is 2028-05-01.

What conditions does trial NCT06279013 study?

This clinical trial studies the following conditions: Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm.

What interventions are being tested in trial NCT06279013?

The interventions under investigation include: Medical Chart Review (OTHER), Interview (OTHER), Health Education (BEHAVIORAL), Counseling (OTHER), Monitoring (OTHER).

Who is sponsoring clinical trial NCT06279013?

This trial is sponsored by NRG Oncology, which has 64 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06279013 being conducted?

This trial has 20 study locations across Arizona, Arkansas, Georgia, Hawaii, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Malignant Solid Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Malignant Solid Neoplasm

All registered trials for this condition

Hematopoietic and Lymphatic System Neoplasm

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.